Plain-English translation of NCT06341933 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some patients experience a temporary decline in kidney function after undergoing minimally invasive lung surgery (called VATS) to treat lung cancer. By carefully monitoring blood tests, urine output, and heart function during and after surgery, this study will help doctors identify which patients are at higher risk and how to better protect kidney function during these procedures.
Kidney injury can sometimes occur after major surgery, but doctors don't yet fully understand which patients are most vulnerable or what surgical factors contribute to this risk. This study aims to fill that gap so future patients can receive better preventive care.
You likely qualify if…
You likely don't qualify if…
You will have blood and urine tests before surgery and at specific times after surgery to monitor your kidney function. During the procedure, doctors will carefully track your urine output and heart function using standard monitoring equipment. You will be checked for complications before you leave the hospital and again 30 days after surgery. The entire study follows your normal surgical care — no extra procedures are added.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Turkey (Türkiye)